US is drafting plans for sale of some unapproved peptides, the Washington Post reports

US is drafting plans for sale of some unapproved peptides, the Washington Post reports

​The ‌Trump ​administration ‌is drafting plans for ‌the ‌temporary sale ⁠of ​some ⁠unapproved ⁠peptides, the Washington ​Post reported ⁠on ⁠Thursday.

(Reporting ​by ⁠Jasper Ward ⁠and Christian ⁠Martinez; ‌Editing ‌by Muralikumar ​Anantharaman)

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.